Small Drug Development SME Businesses: Opportunities Expansion with LifeSciHub

LifeSciHub News

LifeSciHub, a strategic, radically transparent subcontracting channel for drug sponsors to engage with small drug development subject matter expert (SME) businesses, provides an attractive opportunity to small businesses:  the Connector Model.

A small SME business is focused on its “brand”:  its particular area of subject matter expertise, that which it does well, it curates excellent resources for staff and outside consultants, it cultivates its reputation among the drug sponsor client base as providing premier expertise in that subject.  The small business can be focused on any aspect of drug development:  clinical trial management, study start up,  drug safety, biometrics, medical affairs, RWE, medical writing, supply chain, quality, discovery, toxicology, manufacturing, market research, wearables- the list is exhaustive.  These are all highly specific areas of needs within a drug sponsor.  And according to research, sponsors struggle to find and engage resources in all of these areas.

Although small SME businesses may focus on one or possibly two subjects (their “Brand”) it is unlikely they can supply expertise across all aspects of drug development.  They see the opportunity, because sponsors ask them- sponsors like to source from people they trust.  “Hey [RWE small business], do you know any good clinical quality experts?” the drug sponsor asks.  Or perhaps the drug sponsor asks the clinical trial supply small business if they know any good biostatisticians.

At this point, the small SME business has a choice.  Go find a biostatistician and subcontract, because standard subcontracting mark ups start at 30% and go up.  “Easy money!” the small SME business thinks.  But the wise SME business owner wonders, if that biostatistician messes up, that could affect my reputation as a great clinical trial supply supplier.  How would I even know if the biostatistician is doing well or missing the mark?  I can’t project manage biometrics!”.

Although exposed to this demand, the small SME business usually does one of two things:  says no, sorry, or makes an introduction or two in the name of goodwill.

This is where the LifeSciHub Connector model presents an attractive opportunity for small SME businesses.  “Connect” that demand to LifeSciHub, and LifeSciHub will share any revenue generated by that sponsor with your small business, permanently.

As a radically transparent subcontracting engine, LifeSciHub’s fees to drug sponsors are razor thin- LifeSciHub’s fees are razor thin- 20% mark up on the gross of any engagement.  As the Connector, you receive 5%, LifeSciHub keeps 15%.

This enables you, the small SME business to capitalize on the demand you are exposed to, without impacting your Brand in any way.  LifeSciHub would establish a separate Master Services Agreement with your client, but first, an Agreement with you defining the guardrails around your Brand.  In other words, under no circumstances would introducing LifeSciHub into your client base introduce a competitor to your work- the only thing LifeSciHub would do would provide unrelated SME businesses to your drug sponsor client.

No, you won’t earn 30% mark ups in this model, however this is the exact innovation LifeSciHub brings to the drug development vendor ecosystem- 30% is simply too much when contracts and payment processing is the only value the “middleman” is providing.

All LifeSciHub fees are reported in total transparency to both supply and demand, always.  LifeSciHub’s profit and loss statement is presented in full to the users annually, and available for auditing by the members.

If LifeSciHub already has a Master Services Agreement in place, the Connector Model is no longer available for that drug sponsor.  As of Q2 2023, LifeSciHub has very few, so this is an open opportunity for savvy small businesses!  Please contact for more information.